Prescription drug

Texas PBM Steerage Bill Becomes Law

Retrieved on: 
Saturday, June 19, 2021
Health sciences, Health care, Health, Pharmacy, Symbols, Clinical pharmacology, Pharmacy benefit management, Pharmaceuticals policy, Pharmacist, Prescription drug, Medical prescription, Independent pharmacy

AUSTIN, Texas, June 19, 2021 /PRNewswire-PRWeb/ --In a significant victory for Texas pharmacists and their patients, Texas has enacted House Bill 1919, important legislation that protects community pharmacies and ensures patient choice by prohibiting pharmacy benefit managers (PBMs) from steering patients to pharmacies they own.

Key Points: 
  • AUSTIN, Texas, June 19, 2021 /PRNewswire-PRWeb/ --In a significant victory for Texas pharmacists and their patients, Texas has enacted House Bill 1919, important legislation that protects community pharmacies and ensures patient choice by prohibiting pharmacy benefit managers (PBMs) from steering patients to pharmacies they own.
  • The Texas Pharmacy Association (TPA) identified PBM reform as a top priority for the 87th Legislative Session and worked closely with legislators to enact meaningful legislation.
  • TPA is grateful to Texas legislators for recognizing that PBM practices shortchange pharmacists and create barriers, limiting access for patients to receive needed medications from their local pharmacy.
  • In May, Governor Abbott signed into law House Bill 1763, which improves patient access to needed prescription drugs while ensuring pharmacies are protected from PBM overreach.

AHF Files Federal Antitrust Lawsuit Against the PBM Prime Therapeutics

Retrieved on: 
Friday, June 18, 2021
Professional services, AIDS, Public policy, Government, Health, Healthcare reform, Legal, Pharmaceutical, Health sciences, Health care, Health, Symbols, Clinical pharmacology, Pharmacy, Specialty drugs, Pharmaceuticals policy, Pharmacy benefit management, Express Scripts, Medical prescription, Prescription drug

Prime is a pharmacy benefit manager (PBM), a middle-man in the distribution system for prescription drugs in the United States.

Key Points: 
  • Prime is a pharmacy benefit manager (PBM), a middle-man in the distribution system for prescription drugs in the United States.
  • Some of those people are patients of AHF pharmacies, and, in 2020, Prime processed almost 100,000 drug prescriptions for AHF patients.
  • In late 2019, Prime announced a new three-year collaboration with another PBM, Express Scripts, Inc.
  • In fact, it appears Prime is simply aligning its reimbursement rates with those of the other PBM, and doing so on an ongoing basis.

Oregon Department Of Environmental Quality (DEQ) Has Approved The Drug Takeback Solutions Foundation (DTSF) And Their Contracted Provider, Inmar Intelligence, As A Drug Stewardship Plan Operator

Retrieved on: 
Thursday, June 17, 2021
Health sciences, Health, Clinical pharmacology, Substance-related disorders, Pharmaceuticals policy, Medical emergencies, Pharmacy, Drug overdose, Prescription drug, Substance abuse, Heroin, Medical prescription

The program, which will launch July 1, 2021, will provide drug take-back receptacles throughout the state of Oregon and make mail-back envelopes available in hundreds of locations.

Key Points: 
  • The program, which will launch July 1, 2021, will provide drug take-back receptacles throughout the state of Oregon and make mail-back envelopes available in hundreds of locations.
  • Oregon passed the Drug Takeback Law in 2019 due to growing public health concerns surrounding the improper disposal of medications leading to water contamination, and drug diversion resulting in drug overdoses.
  • COVID-19 drastically affected those struggling with substance abuse disorders, with Oregon seeing a nearly 40 percent increase in overdose deaths in 2020 .
  • In an effort to combat prescription drug abuse in Oregon, and protect the states environment from the effects of improper disposal of prescription medications, the Drug Takeback Solutions Foundation is working with the Oregon Department of Environmental Quality and Inmar Intelligence to expand and enhance access to consumer drug take-back options across the state.

NC MedAssist Hosts Inaugural Golf Tournament to Support Under-Resourced Patients with Free Prescription Medication

Retrieved on: 
Monday, June 14, 2021
Health sciences, Health, Pharmacy, Clinical pharmacology, Symbols, Drugs, Pharmaceuticals policy, Prescription drug, Medical prescription, Free clinic, Ready, Set, PrEP

The purpose of the event is to raise funds for North Carolina's only charitable pharmacy, NC MedAssist, which provides free prescription medication to low-income and uninsured state residents.

Key Points: 
  • The purpose of the event is to raise funds for North Carolina's only charitable pharmacy, NC MedAssist, which provides free prescription medication to low-income and uninsured state residents.
  • "Not only does NC MedAssist provide prescription and over-the-counter medications at no cost to North Carolina's more vulnerable neighbors - they also provide hope.
  • NC MedAssist is a charitable pharmacy that serves patients in all 100 North Carolina counties through its Free Pharmacy Program.
  • To donate to NC MedAssist or for more information on the 2021 Dispensing Hope Invitational visit https://medassist.org/golf2021/
    About NC MedAssist: NC MedAssist is a statewide non-profit pharmacy that provides free prescription medication to all low-income, uninsured North Carolinians who qualify for their Free Pharmacy Program.

TELUS Health Drug Trends report: Acute medication claims declined in early months of pandemic

Retrieved on: 
Wednesday, June 9, 2021
Health sciences, Health, Pharmaceuticals policy, Telus, Telus Health, Health insurance, Prescription drug, Prescription drug prices in the United States, Pharmacy benefit management

As a partner to the health benefits community, we remain committed to introducing innovative tools and practices to continue supporting improved employee health.

Key Points: 
  • As a partner to the health benefits community, we remain committed to introducing innovative tools and practices to continue supporting improved employee health.
  • Published annually since 2015, the TELUS Health Drug Trends and National Benchmarks Report considers major trends in private drug plan costs, utilization, and benefits plan management.
  • It provides a snapshot of the previous year, exploring trends in drug claims activities for more than 13 million insured Canadians across 150 million prescription drug claims.
  • TELUS Health is a leader in digital health technology, providing virtual care, home health monitoring, electronic medical and health records, benefits and pharmacy management, and personal emergency response services.

Walmart+ Adds Savings on Prescriptions to Growing Suite of Benefits

Retrieved on: 
Monday, June 7, 2021
MEN, General Health, Online Retail, Other Retail, Pharmaceutical, Discount, Variety, Supermarket, Consumer, Retail, Women, Seniors, Health, Retailers, Retailing, Service companies, Walmart, Bentonville, Arkansas, Pharmacy, Pharmaceuticals policy, Criticism of Walmart, Prescription drug

**

Key Points: 
  • **
    Since 2006, Walmart Pharmacy patients have saved on prescriptions through the retailers industry-changing $4 generics program.
  • And for those looking to save even more on their medications, membership has its benefits.
  • Its been our commitment from the beginning to continue to grow the suite of benefits we offer Walmart+ members.
  • Savings off of the overall regular nationwide retail pharmacy prices based upon 2020 national program savings data from MedImpact; average savings are 65%.

U.S. FDA Accepts PharmaEssentia’s BLA Resubmission for ropeginterferon alfa-2b-njft for the Treatment of Polycythemia Vera (PV)

Retrieved on: 
Thursday, June 3, 2021
Biotechnology, FDA, Health, Pharmaceutical, Clinical trials, Health, Pharmaceuticals policy, Food and Drug Administration, Prescription Drug User Fee Act, Pharmaceutical industry, Orphan drug, Medication, Prescription drug, European Medicines Agency, Synageva, Priority review

The FDA has assigned a six-month review period for the resubmitted application and provided November 13, 2021 as the target Prescription Drug User Fee Act (PDUFA) action date.

Key Points: 
  • The FDA has assigned a six-month review period for the resubmitted application and provided November 13, 2021 as the target Prescription Drug User Fee Act (PDUFA) action date.
  • We eagerly look forward to contributing to advances in care through a new therapeutic solution for this challenging rare blood cancer.
  • Ropeginterferon alfa-2b-njft has Orphan Drug designation for the treatment of PV in the United States.
  • Marketed as Besremi in Europe, the product was approved by the European Medicines Agency (EMA) in 2019.

Suggested Reasons for Price of Prescription Drugs in America

Retrieved on: 
Tuesday, June 1, 2021
Health sciences, Health, Pharmacy, Pharmaceuticals policy, Pharmaceutical industry, Drug pricing, Drugs, Medication costs, Prescription drug, Medication, Prescription drug prices in the United States, Draft:Altrui Foundation

High prescription medication costs are a harsh reality for the average American, and these days relief from paying high costs for life-saving medication is needed more than ever.

Key Points: 
  • High prescription medication costs are a harsh reality for the average American, and these days relief from paying high costs for life-saving medication is needed more than ever.
  • Big pharma always insists there are legitimate reasons why Rx medications are so expensive, but many of them aren't legitimized.
  • Although this holds to be true, profits generated from selling prescription medication cover for those costs and produce tidy profits.
  • In America, companies have patents on their pharmaceuticals, and while the patents are still in place, the prescription medications can be valued at whatever price point they think is best.

AHF Commends Biden Administration, Gov. DeSantis and FL Legislature on Support of Drug Importation from Canada

Retrieved on: 
Saturday, May 29, 2021
Public policy, Government, Healthcare reform, Philanthropy, White House, Federal Government, AIDS, State, Local, Pharmaceutical, Health, Public policy, Foundation, Health sciences, Health, Pharmaceuticals policy, Biden family, Joe Biden, Ron DeSantis, AIDS Healthcare Foundation, Prescription drug, Food and Drug Administration

AIDS Healthcare Foundation ( AHF ) today praised the Biden Administration and Florida Governor Ron DeSantis and the Florida State Legislature for siding with the cause of allowing the importation from Canada safe, US Food and Drug Administration (FDA) approvedand less expensiveprescription drugs in filings submitted in a federal lawsuit.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) today praised the Biden Administration and Florida Governor Ron DeSantis and the Florida State Legislature for siding with the cause of allowing the importation from Canada safe, US Food and Drug Administration (FDA) approvedand less expensiveprescription drugs in filings submitted in a federal lawsuit.
  • Bipartisan support of such drug importation was reported by Politico last evening ( 5/28/21 ) in a story that reported the Biden administration filed a motion in federal court seeking to dismiss a lawsuit that aims to prevent prescription drug imports from Canada a plan Florida is lobbying to utilize.
  • The Biden administration requested the court to dismiss the drug companies lawsuit.
  • Were very pleased the drug industrys scare tactics failed to gain any traction with either President Biden or Governor DeSantis especially since most prescription drugs are already manufactured outside the United States anyway.

US Onychomycosis Market Size, Trends & Forecasts Report 2021-2025: Distal Subungual, White Superficial, Proximal Subungual, Endonyx and Candidal Onychomycosis - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 27, 2021
Health, Other Health, Health sciences, Health, Onychomycosis, Prescription drug, Nail, Antifungals

3.1 Global Nail Care Market: An Analysis

Key Points: 
  • 3.1 Global Nail Care Market: An Analysis
    4.1 The US Nail Care Market: An Analysis
    4.2 The US Onychomycosis Market: An Analysis
    4.3 The US Onychomycosis Market: Type of Treatment Analysis
    4.4 The US Onychomycosis Market: Drug Availability Analysis
    4.5 The US Onychomycosis Market: Prescription Drugs Analysis
    4.6 The US Onychomycosis Market: OTC Drugs Analysis
    5.1 Competition in Onychomycosis Prescription Market: An Overview